Literature DB >> 10626115

Disorders of hyperpigmentation.

A G Pandya1, I L Guevara.   

Abstract

Hyperpigmentation is a common disorder of the skin, particularly in brown-skinned patients. Melasma is a common cause of facial hyperpigmentation and can be resistant to treatment. A combination of topical creams and gels, chemical peels, and sunscreens may be necessary for significant improvement. Erythema dyschromicum perstans is a dermal pigmentation seen on the trunk and proximal extremities, most commonly presenting in dark-skinned Hispanics. Drug-induced and postinflammatory hyperpigmentation may last for many months after the offending drug or dermatitis has been eliminated. These disorders, including their management, is reviewed in this article.

Entities:  

Mesh:

Year:  2000        PMID: 10626115     DOI: 10.1016/s0733-8635(05)70150-9

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  26 in total

1.  Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing.

Authors:  Marta I Rendon; Diane S Berson; Joel L Cohen; Wendy E Roberts; Isaac Starker; Beatrice Wang
Journal:  J Clin Aesthet Dermatol       Date:  2010-07

2.  The Inhibitory Effect of Phytoclear-EL1 on Melanogenesis.

Authors:  Kee Suck Suh; Jae Woo Baek; Tae Kwon Kim; Jin Woo Lee; Hyo Jin Roh; Young Seung Jeon; Sang Tae Kim
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

Review 3.  [Skin changes with chemotherapy].

Authors:  A L Branzan; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2005-06       Impact factor: 0.751

Review 4.  Can you identify this condition? Melasma.

Authors:  Patricia T Ting; Benjamin Barankin
Journal:  Can Fam Physician       Date:  2005-03       Impact factor: 3.275

Review 5.  [Fractional photothermolysis: a new option for treating melasma?].

Authors:  S Karsai; C Raulin
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

6.  Effects of trans-4-(aminomethyl) cyclohexanecarboxylic acid/potassium azeloyl diglycinate/niacinamide topical emulsion in Thai adults with melasma: a single-center, randomized, double-blind, controlled study.

Authors:  Jarupa Viyoch; Isaree Tengamnuay; Khemjira Phetdee; Punpimol Tuntijarukorn; Neti Waranuch
Journal:  Curr Ther Res Clin Exp       Date:  2010-12

7.  Down-regulation of tyrosinase, TRP-1, TRP-2 and MITF expressions by citrus press-cakes in murine B16 F10 melanoma.

Authors:  Sang Suk Kim; Min-Jin Kim; Young Hun Choi; Byung Kok Kim; Kwang Sik Kim; Kyung Jin Park; Suk Man Park; Nam Ho Lee; Chang-Gu Hyun
Journal:  Asian Pac J Trop Biomed       Date:  2013-08

Review 8.  Melasma in Men: A Review of Clinical, Etiological, and Management Issues.

Authors:  Rashmi Sarkar; Pallavi Ailawadi; Shilpa Garg
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

9.  The prevalence of melasma and its association with quality of life in adult male Latino migrant workers.

Authors:  Rita Pichardo; Quirina Vallejos; Steven R Feldman; Mark R Schulz; Amit Verma; Sara A Quandt; Thomas A Arcury
Journal:  Int J Dermatol       Date:  2009-01       Impact factor: 2.736

10.  The use of retinoic acid in association with microneedling in the treatment of epidermal melasma: efficacy and oxidative stress parameters.

Authors:  Clarissa L M da Silva Bergmann; Daniela Pochmann; Julio Bergmann; Fernanda Brasil Bocca; Isabel Proença; Jessica Marinho; Alexandre Mello; Caroline Dani
Journal:  Arch Dermatol Res       Date:  2020-09-25       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.